Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1 depends on activation of STAT5 (signal transducer and activator of transcription 5)
Bn. Friedrichsen et al., Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1 depends on activation of STAT5 (signal transducer and activator of transcription 5), MOL ENDOCR, 15(1), 2001, pp. 136-148
GH and PRL stimulate proliferation and insulin production of pancreatic bet
a -cells. Whereas GH- and PRL-regulated transcription of the insulin gene i
n insulinoma cells has been shown to depend on STAT5 (signal transducer and
activator of transcription 5), the signaling pathways involved in GH/PRL-i
nduced p-cell replication are unknown. The roles of various signaling pathw
ays in human GH (hGH)-induced DNA synthesis were studied by analysis of the
effect of specific inhibitors in both the insulin-producing cell line, INS
-1, and in primary beta -cells. The mitogen-activated protein kinase kinase
(MEK)-inhibitor, PD98059, as well as the mitogen-activated protein kinase
p38 (MAPKp38) inhibitor, SB203580, partially inhibited hGH-induced prolifer
ation in INS-1 cells but had no significant effect in primary beta -cells.
Staurosporine, a protein kinase C (PKC) and protein kinase A (PKA) inhibito
r, blocked both basal and hGH-induced proliferation in INS-1 cells, but had
no inhibitory effect in primary beta -cells. Wortmannin, a phosphatidytino
sitol 3-kinase (P13K) inhibitor, inhibited hGH-induced proliferation neithe
r in INS-1 cells nor in primary beta -cells, whereas the tyrosine kinase in
hibitor, genistein, completely inhibited hGHinduced proliferation in both p
rimary beta -cells and INS-1 cells. To analyze the possible role of STAT5 i
n hGH-induced proliferation, a dominant negative STAT5 mutant, STAT5 Delta
49, was expressed in INS-1 cells under the control of a doxycycline-inducib
le promoter by stable transfection. Two clones were found to exhibit dose-d
ependent, doxycycline-inducible expression of STAT5 Delta 749 and suppressi
on of hGH-stimulated transcriptional activation of a STAT5-regulated PRL re
ceptor (PRLR) promoter-reporter construct. Furthermore, induction of STAT5
Delta 749 expression completely inhibited hGH-induced DNA synthesis. Analys
is of endogenous gene expression revealed a doxycycline-dependent inhibitio
n of hGH-stimulated PRLR and cyclin D2 mRNA levels. Our results suggest tha
t GH/PRL-induced beta -cell proliferation is dependent on the Janus Kinase2
(JAK2)/STAT5 signaling pathway but not the MAPK, PI3K, and PKC signaling p
athways. Furthermore, the cell cycle regulator cyclin D2 may be a crucial t
arget gene for STAT5 in this process.